As previously mentioned, BACE1 in AD is characterized by the increased existence of bisecting GlcNAc on its glycosylation sites which seems to cause an increase in Aβ formation because such post-transcriptional modification causes a decrease in lysosomal degradation of BACE1 (Kizuka et al., 2015). The gene discussed is BACE1; the disease is Alzheimer disease.